| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |